HSE to shave tens of millions off drug bill with launch of cheaper alternative
Mylan has launched a new drug that will result in significant price savings on the state’s €124 million annual bill for Humira, which the HSE spends more on than any other drug on the market.
Humira, a biological drug that is manufactured by AbbVie, is predominantly used to treat rheumatoid arthritis, but also Crohn’s disease, colitis and psoriasis. The HSE pays approximately €1,080 per month for a dose of Humira (80mg), but that...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Tony O’Brien: Health’s other challenges now need the same urgent care as Covid
Our collective understanding of the value of the health service has been transformed over the last 12 months. Now is the time for Stephen Donnelly to grab the initiative and push through meaningful reforms
New public-only deals for medical consultants set for this summer
The contracts, worth up to €252,000 a year, will mean that hospital consultants hired by the HSE can only work in public settings
HSE contacts Data Protection Commission over ransomware attack
It is unclear yet if individual personal data has been compromised as part of ‘sophisticated’ cyber attack
Comment: Our reserves were not built to survive long Covid
The Asthma Society of Ireland wants to end deaths from the condition by 2030, but the prolonged pandemic has heaped pressure on its services